Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.
The use of rFVIIa in conditions associated with disseminated intravascular coagulation (DIC) has always been an area of concern in view of the theoretical possibility of enhancing thrombotic complications. However, […]